Autolus Therapeutics (AUTL) Receivables: 2022-2025
Historic Receivables for Autolus Therapeutics (AUTL) over the last 1 years, with Sep 2025 value amounting to $33.5 million.
- Autolus Therapeutics' Receivables was N/A to $33.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.0 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2024, which is 129.76% up from last year.
- As of Q3 2025, Autolus Therapeutics' Receivables stood at $33.5 million, which was up 22.82% from $27.3 million recorded in Q2 2025.
- Autolus Therapeutics' 5-year Receivables high stood at $33.5 million for Q3 2025, and its period low was $625,000 during Q4 2023.
- In the last 3 years, Autolus Therapeutics' Receivables had a median value of $8.6 million in 2023 and averaged $13.4 million.
- As far as peak fluctuations go, Autolus Therapeutics' Receivables tumbled by 59.83% in 2023, and later surged by 129.76% in 2024.
- Quarterly analysis of 4 years shows Autolus Therapeutics' Receivables stood at $1.6 million in 2022, then plummeted by 59.83% to $625,000 in 2023, then surged by 129.76% to $1.4 million in 2024, then reached $33.5 million in 2025.
- Its Receivables was $33.5 million in Q3 2025, compared to $27.3 million in Q2 2025 and $14.7 million in Q1 2025.